Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Dermatol Online J ; 21(9)2015 Sep 17.
Artigo em Inglês | MEDLINE | ID: mdl-26437295

RESUMO

This paper describes a case of pruritus caused by dysmetabolic hyperferritinemia treated by multiple phlebotomies. A 63-year-old man was followed for generalized pruritus, which was resistant to the usual treatments. He presented with metabolic syndrome. Physical examination showed only excoriations and lichenification on the skin. The serum ferritin was high at 1043 ng/ml, with transferrin saturation at 67%. The other biological investigations and genetic tests for hemochromatosis were negative. In spite of the dietary measures, the ferritin level was still high (853 ng/ml). Magnetic resonance imaging confirmed hepatic iron overload.The association of hyperferritinemia, hepatic iron overload, and metabolic syndrome led to the diagnosis of dysmetabolic hyperferritinemia. Phlebotomies are an unusual treatment, but because the pruritus and hyperferritinemia were still present, phlebotomy was initiated. After 19 months, the patient reported improvement of his pruritus and normalization of ferritin levels.


Assuntos
Ferritinas/sangue , Sobrecarga de Ferro/complicações , Sobrecarga de Ferro/terapia , Síndrome Metabólica/complicações , Flebotomia , Prurido/etiologia , Humanos , Sobrecarga de Ferro/sangue , Masculino , Pessoa de Meia-Idade , Transferrina/metabolismo
2.
J Hematol Oncol ; 10(1): 21, 2017 01 19.
Artigo em Inglês | MEDLINE | ID: mdl-28103947

RESUMO

The determinants of clinical responses after autologous hematopoietic stem cell transplantation (aHSCT) in systemic sclerosis (SSc) are still unraveled. We analyzed long-term immune reconstitution (IR) and T cell receptor (TCR) repertoire diversity in 10 SSc patients, with at least 6 years simultaneous clinical and immunological follow-up after aHSCT. Patients were retrospectively classified as long-term responders (A, n = 5) or non-responders (B, n = 5), using modified Rodnan's skin score (mRSS) and forced vital capacity (FVC%). All patients had similar severe SSc before aHSCT. Number of reinjected CD34+ cells was higher in group B versus A (P = 0.02). Long-term mRSS fall >25% was more pronounced in group A (P = 0.004), the only to improve long-term FVC% >10% (P = 0.026). There was an overall trend toward increased of T cell reconstitution in group B versus A. B cells had a positive linear regression slope in group A (LRS = 11.1) and negative in group B (LRS = -11.6). TCR repertoire was disturbed before aHSCT and the percentage of polyclonal families significantly increased at long-term (P = 0.046), with no difference between groups. Despite improved skin score after aHSCT in all SSc patients, pretransplant B cell clonal expansion and faster post-transplant T cell IR in long-term non-responder/relapsing patients call for new therapeutic protocols guided by IR analysis to improve their outcome.


Assuntos
Transplante de Células-Tronco Hematopoéticas , Esclerodermia Difusa/terapia , Subpopulações de Linfócitos T/imunologia , Adulto , Antígenos de Diferenciação de Linfócitos T/análise , Contagem de Células , Feminino , Seguimentos , Sobrevivência de Enxerto , Humanos , Imunofenotipagem , Masculino , Pessoa de Meia-Idade , Esclerodermia Difusa/imunologia , Esclerodermia Difusa/patologia , Índice de Gravidade de Doença , Pele/imunologia , Pele/patologia , Transplante Autólogo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa